Is Longevity a $1.2 Quadrillion Opportunity?
Peter Diamandis released the 2026 Longevity Metatrend Report, a free 200‑page analysis of the rapidly advancing health‑span sector. The report highlights breakthroughs such as human trials of partial epigenetic reprogramming, AI‑engineered proteins achieving 50‑fold efficacy gains, and the first pig‑organ transplants into patients. It also notes wearable health platforms surpassing $10 billion valuations and a surge of capital, with companies raising between $280 million and $1 billion. ARK Invest estimates the total addressable market for longevity interventions at $1.2 quadrillion.
Scientific Superintelligence: The Deep Blue Moment
In 2026 AI systems are autonomously executing the full scientific method, from hypothesis generation to experimental iteration, at machine speed. Lila Sciences, backed by Flagship Pioneering, has built the first AI‑driven "Science Factories" that operate across biology, chemistry, materials and...
How AI Will "Feel" In 2 Years
The piece forecasts that within two years AI will evolve from a discrete app into an always‑on, ambient intelligence layer that orchestrates daily life. Five concurrent shifts are highlighted: unrestricted personal data access turning AI into a chief‑of‑staff, environments auto‑adjusting...
A Disruptive Moment in Time…
This week AI leaders signaled a turning point: OpenAI’s Sam Altman advocated a four‑day workweek while warning of cyber and bio‑terror threats, and Anthropic announced its most powerful model, Claude Mythos, but refused public release, restricting it to a 40‑company...